{"nct_id":"NCT03443024","title":"A Study of Lebrikizumab (LY3650150) in Participants With Moderate-to-Severe Atopic Dermatitis","status":"COMPLETED","status_verified_date":"2020-07","start_date":"2018-01-30","start_date_type":"ACTUAL","primary_completion_date":"2019-02-07","primary_completion_date_type":"ACTUAL","completion_date":"2019-05-23","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["LLY"]}